Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

SPCX Space Exploration Technologies Corp. Class A Common Stock
$162.57 1.25% +2.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SPCX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 2.1T
Enterprise value 4.2T
Trailing PE -318.80391438802
Forward PE 83.28979
PEG Ratio 83.28979
Enterprise to EBITDA 716.572
Enterprise to revenue 183.372
Price to book MRQ 16.836164
Price to sales TTM 92.99436

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 23.0B
EBITDA 5.0B
Diluted EPS TTM -1.1
Total Cash (MRQ) 100.0B
Current ratio (MRQ) 5.115
Operating Cash Flow (TTM) 9.9B

SPCX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.